Clinical associations of anti-lamin autoantibodies

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 2, 1996, Pages 162-166

  Hill, C ^a,d   Roberts Thomson, P ^b   Pollard, A ^a   Gillis, D ^c   Kirkham, B ^a,e  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d Queen Elizabeth Hospital ^*  (Australia)

^e ST GEORGE HOSPITAL   (Australia)

Author keywords

anti lamin autoantibodies

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; LAMIN;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; FEMALE; HEP 2 CELL; HUMAN; IMMUNOFLUORESCENCE; MALE; PATHOGENESIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029994822     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb00879.x     Document Type: Article

References (18)

1. Franke WW. Nuclear lamins and cytoplasmic intermediate filament proteins: A growing multigene family. Cell 1987; 48: 3-4.
2. Gerace L, Biobel G. The nuclear envelop lamina is reversibly depolymerized during mitosis. Cell 1980; 19: 277-87.
3. Fisher DZ, Chaudhury N, Biobel G. cDNA sequencing of nuclear lamins A and C reveals primary and secondary homology to intermediate filament proteins. Proc Natl Acad Sci USA 1986; 83: 6450-4.
4. Tan EM. Autoantibodies to nuclear lamins. Ann Intern Med 1988; 108: 897-8.
5. Lassoued K, Guilly MN, Danon F et al. Antinuclear autoantibodies specific for lamins: Characterisation and clinical significance. Ann Intern Med 1988; 108: 829-33.
6. Harris EN. The Second International Anti-cardiolipin Standardization Workshop/The Kingston Anti-phospholipid Antibody Study (KAPS) Group. Am J Clin Path 1990; 94: 476-84.
7. Tan EM, Cohen AJ, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
8. Harris EN. Syndrome of the Black Swan. Br J Rheum 1987; 26: 324-7.
9. McKeon FD, Tuffanelli DA, Fukuyama K, Kischner MW. Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci USA 1973; 80: 4374-8.
10. Guilly MN, Danon F, Brouet JC, Bornens M, Courvalin JC. Autoantibodies to nuclear lamin B in a patient with thrombopenia. Eur J Cell Biol 1987: 43: 266-72.
11. Lassoued S, Okaman E, Fournie B, Danon F, Fournie A, Lassoued K. Autoantibodies to lamins in rheumatoid arthritis. Arthritis Rheum 1990; 33: 877-9.
12. Wesierka-Gadek J, Penner E, Hitchman E, Sauermann G. Antibodies to nuclear lamin C in chronic hepatitis delta virus infection. Hepatology 1990; 12: 1129-33.
13. Varga J, Maul GG, Jimenez SA. Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Arthritis Rheum 1992; 35: 106-8.
14. Wesierka-Gadek J, Penner E, Hitchman E, Sauermann G. Antibodies to nuclear lamins in autoimmune liver disease. Clin Immunol Immunopath 1988; 49: 107-15.
15. Reeves WH, Chaudhury N, Salernao A, Blobel G. Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus. J Exp Med 1987; 165: 750-2.
16. Konstantinov K, Halberg P, Wilk A et al. Clinical manifestations in patients with autoantibodies specific for nuclear lamin proteins. Clin Immunol Immunopathol 1992; 62: 112-8.
17. Toh BH. Anti-cytoskeletal autoantibodies: diagnostic significance for liver diseases, infections and systemic autoimmune diseases. Autoimmunity 1991; 11: 119-25.
18. Senecal JL, Raymond Y. Autoantibodies to major and minor nuclear lamins are not restricted to autoimmune diseases. Clin Immunol Immunopathol 1992; 63: 115-25.